We are calling out to the world’s most exciting start-ups to exhibit their businesses at World Vaccine Congress Washington 2025.
It will provide a unique environment to meet VCs looking for early stage opportunities as well as companies across pharma, biotech, healthcare, academia, chemicals, food, animal health and computer science and the community that serves them.
Other benefits:
• 2X full access pass
• Access to Terrapinn Events App to pre-arrange 1-1 meetings at the Congress on private pre-booked tables
• Access to Networking Reception Drinks
• Branding on event materials & marketing awareness from the Congress
• Listing on event Web Pages
Additional options:
Application Period: ASAP as there are limited spaces left
We're developing first-in-class inhalable and infection-activated RNA therapeutics from COVID-19 and influenza to RSV. Our lead candidate provides single-administration protection against any coronavirus.
USSF located in Allentown, Pennsylvania, Dr. Flanigan is leading his team to bring QYNDR, an oral mucosal vaccine delivery platform currently targeting the COVID-19 vaccine, to market – one that will be easier to use, longer lasting and with fewer...